NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$6.47
−2.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 39.88x
- PEG TTM
- 1.23x
- Price / book
- 9.41x
- Price / sales
- 19.84x
- Price / cash flow
- -42.11x
Enterprise value
- Enterprise value
- $271.9M
- EV / sales
- 19.01x
- EV / EBITDA
- 52.76x
- EV / EBIT
- 45.75x
- Market cap
- $283.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025